← Back to Clinical Trials
Recruiting NCT06536088

NCT06536088 The Relationship Between Gait and Severity of Femoroacetabular Impingement

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06536088
Status Recruiting
Phase
Sponsor Gazi University
Condition Femoroacetabular Impingement
Study Type OBSERVATIONAL
Enrollment 25 participants
Start Date 2022-01-01
Primary Completion 2024-09-30

Trial Parameters

Condition Femoroacetabular Impingement
Sponsor Gazi University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2022-01-01
Completion 2024-09-30
Interventions
Walking assesment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this study, the spatiotemporal gait parameters of symptomatic femoroacetabular impingement (FAI) patients scheduled for hip arthroscopy are evaluated. Radiological measurements, including the Alpha angle (AA), Lateral Center-Edge Angle (LCEA), and Kellgren-Lawrence (KL) osteoarthritis classification, are recorded from patient files. The relationship between these radiological measurements and walking parameters is assessed. Additionally, the spatiotemporal gait parameters of FAI patients are compared with those of a healthy control group. Walking assessments provide valuable insights into how Femoroacetabular Impingement (FAI) affects movement and aid in evaluating treatment outcomes. Research indicates that individuals with FAI experience reduced hip motion and slower walking speeds. By analyzing spatiotemporal gait parameters-such as gait velocity, cadence, step length, and vertical center of mass-the impact of FAI on walking can be better understood, leading to the development of targeted treatment strategies. The goal is to explore the correlation between these gait parameters and imaging-based FAI characteristics in affected individuals.

Eligibility Criteria

Inclusion Criteria: * Patients with femoroacetabular impingement scheduled for hip arthroscopy Exclusion Criteria: * Severe hip osteoarthritis * Hip dysplasia * Previous ipsilateral and/or contralateral hip surgery, * Any orthopedic or neurologic pathology that may affect gait patterns

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology